|
|||||
|
|
Factors associated with switching from sulphonylureas to dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in the United States |
|
| Authors: | Xi Tan PhD Lingfeng Yang PhD Kamlesh Khunti MD Ruya Zhang MD Ye Zhang MD Swapnil Rajpathak MBBS Miao Yu MD |
| Affiliation: | 1. Merck & Co., Inc., Kenilworth, New Jersey, USA;2. Diabetes Research Centre, University of Leicester, Leicester, UK;3. MSD China Holding Company, Shanghai, China;4. Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China |
| Abstract: | |
| Keywords: | cohort study database research DPP-4 inhibitor observational study sulphonylureas type 2 diabetes |